122 related articles for article (PubMed ID: 37310397)
21. Patterns of colorectal cancer diagnosis among younger adults in a real-world, population-based cohort.
Abdel-Rahman O; Karachiwala H; Koski S
Future Oncol; 2022 Jan; 18(1):47-54. PubMed ID: 34763528
[TBL] [Abstract][Full Text] [Related]
22. Surgical management of colorectal peritoneal metastases: treatment and outcomes compared with hepatic metastases.
Tan GH; Teo MC; Chen W; Lee SY; Ng DW; Tham CK; Soo KC
J Gastrointest Cancer; 2013 Jun; 44(2):170-6. PubMed ID: 23138597
[TBL] [Abstract][Full Text] [Related]
23. Synchronous Neoplasia Rates at Colonoscopic Diagnosis of Early-Onset vs Average-Onset Colorectal Cancer.
Emiloju OE; Saberzadeh-Ardestani B; Sinicrope FA
JAMA Netw Open; 2023 Jul; 6(7):e2324038. PubMed ID: 37462969
[TBL] [Abstract][Full Text] [Related]
24. Cytoreductive surgery in combination with hyperthermic intraperitoneal chemotherapy improves survival in patients with colorectal peritoneal metastases compared with systemic chemotherapy alone.
Mirnezami R; Mehta AM; Chandrakumaran K; Cecil T; Moran BJ; Carr N; Verwaal VJ; Mohamed F; Mirnezami AH
Br J Cancer; 2014 Oct; 111(8):1500-8. PubMed ID: 25225906
[TBL] [Abstract][Full Text] [Related]
25. Thirty-three long-term survivors after cytoreductive surgery in patients with peritoneal metastases from colorectal cancer: a retrospective descriptive study.
Kamada Y; Hida K; Ishibashi H; Sako S; Mizumoto A; Ichinose M; Padmanabhan N; Yoshida S; Yonemura Y
World J Surg Oncol; 2021 Jan; 19(1):31. PubMed ID: 33509224
[TBL] [Abstract][Full Text] [Related]
26. Clinical and molecular characterization of early-onset colorectal cancer.
Willauer AN; Liu Y; Pereira AAL; Lam M; Morris JS; Raghav KPS; Morris VK; Menter D; Broaddus R; Meric-Bernstam F; Hayes-Jordan A; Huh W; Overman MJ; Kopetz S; Loree JM
Cancer; 2019 Jun; 125(12):2002-2010. PubMed ID: 30854646
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of doubling time in patients undergoing radical surgery for metachronous peritoneal metastases of colorectal cancer.
Miyake H; Murono K; Nagata H; Nozawa H; Kawai K; Hata K; Tanaka T; Nishikawa T; Shuno Y; Sasaki K; Ishihara S
Int J Colorectal Dis; 2019 May; 34(5):801-809. PubMed ID: 30739186
[TBL] [Abstract][Full Text] [Related]
28. Synchronous and Metachronous Peritoneal Metastases in Patients with Left-Sided Obstructive Colon Cancer.
Veld JV; Wisselink DD; Amelung FJ; Consten ECJ; de Wilt JHW; de Hingh I; Bemelman WA; van Hooft JE; Tanis PJ;
Ann Surg Oncol; 2020 Aug; 27(8):2762-2773. PubMed ID: 32170481
[TBL] [Abstract][Full Text] [Related]
29. Effect of 5-Fluoro-Uracile + Oxaliplatin chemotherapy on the histological response of PEritoneal and hePatIc corectal metasTases in a mOuse model: PEPITO experimental study.
Perrin ML; Bardet SM; Yardin C; Durand Fontanier S; Taibi A
Eur J Surg Oncol; 2023 Mar; 49(3):619-625. PubMed ID: 36443179
[TBL] [Abstract][Full Text] [Related]
30. Hyperthermic Intraperitoneal Chemotherapy (HIPEC) at the Time of Primary Curative Surgery in Patients with Colorectal Cancer at High Risk for Metachronous Peritoneal Metastases.
Baratti D; Kusamura S; Iusco D; Gimondi S; Pietrantonio F; Milione M; Guaglio M; Bonomi S; Grassi A; Virzì S; Leo E; Deraco M
Ann Surg Oncol; 2017 Jan; 24(1):167-175. PubMed ID: 27519353
[TBL] [Abstract][Full Text] [Related]
31. More Synchronous Peritoneal Disease but Longer Survival in Younger Patients with Carcinomatosis from Colorectal Cancer Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Solomon D; DeNicola NL; Feferman Y; Bekhor E; Reppucci ML; Feingold D; Aycart SN; Magge DR; Golas BJ; Labow DM; Sarpel U
Ann Surg Oncol; 2019 Mar; 26(3):845-851. PubMed ID: 30643994
[TBL] [Abstract][Full Text] [Related]
32. A relationship to survival is seen by combining the factors of mismatch repair status, tumor location and age of onset in colorectal cancer patients.
Li P; Xiao Z; Braciak TA; Ou Q; Chen G; Oduncu FS
PLoS One; 2017; 12(3):e0172799. PubMed ID: 28253296
[TBL] [Abstract][Full Text] [Related]
33. Clinical features and prognostic factors of brain metastases from colorectal cancer: a single center experience.
Gao Z; Jin X; Wu S
Int J Colorectal Dis; 2023 Jul; 38(1):198. PubMed ID: 37466736
[TBL] [Abstract][Full Text] [Related]
34. Survival Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in Patients with Synchronous Versus Metachronous Onset of Peritoneal Metastases of Colorectal Carcinoma.
Dietz MV; van Kooten JP; Said I; Brandt-Kerkhof ARM; Verhoef C; Bremers AJA; de Wilt JHW; de Reuver PR; Madsen EVE
Ann Surg Oncol; 2022 Oct; 29(11):6566-6576. PubMed ID: 35513588
[TBL] [Abstract][Full Text] [Related]
35. Incidence and risk factors of metachronous colorectal neoplasm after curative resection of colorectal cancer in Korean patients.
Lee SY; Kim BC; Han KS; Hong CW; Sohn DK; Park SC; Kim SY; Baek JY; Chang HJ; Kim DY; Oh JH
J Dig Dis; 2014 Jul; 15(7):367-76. PubMed ID: 24773758
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology and familial risk of synchronous and metachronous colorectal cancer: a population-based study in Utah.
Samadder NJ; Curtin K; Wong J; Tuohy TM; Mineau GP; Smith KR; Pimentel R; Pappas L; Boucher K; Garrido-Laguna I; Provenzale D; Burt RW
Clin Gastroenterol Hepatol; 2014 Dec; 12(12):2078-84.e1-2. PubMed ID: 24768809
[TBL] [Abstract][Full Text] [Related]
37. The Prognostic Relevance of Histological Subtype in Patients With Peritoneal Metastases From Colorectal Cancer: A Nationwide Population-Based Study.
Razenberg LG; van Gestel YR; Lemmens VE; de Wilt JH; Creemers GJ; de Hingh IH
Clin Colorectal Cancer; 2015 Dec; 14(4):e13-9. PubMed ID: 26140733
[TBL] [Abstract][Full Text] [Related]
38. Effect of the learning curve of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) on the treatment of colorectal peritoneal metastasis.
Chidambarasamy ES; Chia CS; Johnny Ong CA; Soo KC; Ching Teo MC; Ching Tan GH
Asian J Surg; 2022 Jan; 45(1):339-345. PubMed ID: 34148748
[TBL] [Abstract][Full Text] [Related]
39. Prospective randomized trial evaluating mandatory second look surgery with HIPEC and CRS vs. standard of care in patients at high risk of developing colorectal peritoneal metastases.
Ripley RT; Davis JL; Kemp CD; Steinberg SM; Toomey MA; Avital I
Trials; 2010 May; 11():62. PubMed ID: 20500867
[TBL] [Abstract][Full Text] [Related]
40. Impact of ovarian metastases on survival in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancy originating from appendiceal and colorectal cancer.
Bignell MB; Mehta AM; Alves S; Chandrakumaran K; Dayal SP; Mohamed F; Cecil TD; Moran BJ
Colorectal Dis; 2018 Aug; 20(8):704-710. PubMed ID: 29502336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]